Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,428,464
+$12,098,593 QoQ
Shares Held
2,897,078
+7769.1% QoQ
Ownership
0.832%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 85%
Shared 15%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERICAN CENTURY COMPANIES INC holds $3,844,388,733 across 170 Biotechnology names. NUVB ranks #44 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,802,363 | $596,347,845 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
562,097 | $434,298,626 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
813,285 | $363,164,283 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,397,119 | $319,563,028 | |
| 5 | INSM |
INSMED Inc
|
925,799 | $151,386,652 | |
| 6 | ARGX |
Argenx SE
|
173,700 | $126,844,425 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,663,803 | $124,934,967 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
4,138,416 | $102,467,180 |
All Filings in NUVB
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,428,464 | 2,897,078 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $329,871 | 36,816 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,344,719 | 633,708 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,068,461 | 547,929 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $856,301 | 486,535 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,093,720 | 411,173 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $782,142 | 341,547 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $710,605 | 243,358 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $401,925 | 110,419 | Shares | Defined | 2024-05-14 | |
| 2023-06-30 | $89,224 | 49,569 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $45,643 | 27,496 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $45,290 | 23,589 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $35,311 | 15,764 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $39,187 | 12,095 | Shares | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||